Optogenetics gives brain researchers a precise way to test what neurons do

Karl Deisseroth, Peter Hegemann and Georg Nagel received the 2026 Nobel Prize in Physiology or Medicine on 5 October for discoveries underpinning optogenetics.

The Nobel Assembly announced the award at the Karolinska Institute in Stockholm. The three scientists will divide 12 million Swedish kronor, with the formal presentation scheduled for December.

The recognised work concerns light-gated ion channels and the development of a method that allows researchers to activate or silence selected nerve cells in a living brain. Reports from ETV Bharat, Le Monde and HuffPost identified the same three laureates and optogenetics as the field recognised by the 2026 prize.

How an algal protein became a switch for neurons

The scientific path began with channelrhodopsin, a light-sensitive protein discovered by Hegemann and Nagel in a single-celled alga. In its original setting, the protein responds to light. That property provided the biological component needed to make the activity of other cells sensitive to illumination.

Deisseroth introduced channelrhodopsin into nerve cells and demonstrated that blue light could prompt them to send a signal. He subsequently showed that the technique worked inside the brains of living mice, taking it beyond isolated cells and establishing its value for studying active neural systems.

This sequence is central to the award. One discovery supplied a molecular component that reacts to light, while the later work turned that component into an experimental means of controlling neurons. Optogenetics emerged from their combination.

The method does not mean that ordinary brain cells naturally behave like light switches. Scientists first give particular cells the capacity to respond to a chosen wavelength by introducing a light-sensitive protein. Light is then delivered to the relevant area, allowing those modified cells to be influenced at a selected time.

Blue light can open the channelrhodopsin channels in the targeted cells. The resulting movement of ions across the cell membrane can generate a nerve signal. Depending on the light-sensitive tool being used, an optogenetic experiment can switch cellular activity on or off.

The important distinction is selectivity. Rather than altering an entire region indiscriminately, researchers can focus on individual nerve cells or defined populations of cells within a circuit. They can then observe what changes when those cells become active or fall silent.

What light control reveals inside a living brain

The brain contains densely connected networks whose parts can be active almost simultaneously. Observing activity may reveal that a group of neurons participates in a process, but observation alone does not necessarily show what those cells contribute.

Optogenetics adds an intervention. If activating a selected set of nerve cells changes a behaviour, feeling or memory-related process, researchers gain evidence about that set’s role within the wider circuit. Silencing the same cells can provide a complementary test. The ability to time the light precisely also helps scientists examine events that unfold rapidly.

In practical terms, optogenetics joins three elements: a light-responsive protein, a way of placing it in chosen nerve cells and controlled illumination. Together, they let scientists alter a defined part of a functioning neural network while monitoring the outcome.

This does not amount to complete command of a brain. The technique addresses selected cells under experimental conditions, while memories, emotions and behaviours arise from complicated interactions across many cells and circuits. Its value lies in testing the contribution of particular components rather than reducing an entire mental process to one neural switch.

The method forms part of a broader scientific effort to connect events within cells to functions at the level of tissues and organisms. Related research into how cells maintain and regulate biological systems can be found in Sterling Times’ coverage of mechanisms that stabilise genes inside cells.

From mapping circuits to attempts to restore sight

Optogenetics gives researchers a controlled way to test neural circuits rather than merely record them. Current uses and possible medical relevance fall into distinct categories:

• Memory: researchers can activate or suppress chosen nerve cells to investigate how particular circuits contribute to the formation or expression of memories.
• Feelings and behaviour: changing activity in defined cell populations helps test their involvement in emotional states and behavioural responses.
• Neurological and psychiatric research: scientists use the method to examine circuits relevant to disorders, although this research role does not itself make optogenetics an established treatment.
• Vision research: investigators are attempting to use optogenetic methods to restore sight in people with visual impairment. These efforts remain attempts rather than proof of a generally available therapy.

The work on vision follows the same core principle but applies it to cells involved in receiving or relaying visual information. Making selected cells responsive to light could offer another route for generating a signal when normal light-sensing mechanisms have been impaired.

That research has a different status from the laboratory method honoured by the Nobel Prize. Optogenetics is already an instrument for investigating living neural circuits. Restoring sight is a clinical objective being pursued with the technique, not an outcome established for everyone with visual impairment.

The 2026 award therefore recognises both a molecular discovery and the experimental system built from it. Channelrhodopsin supplied the light-sensitive mechanism, and its use in neurons gave scientists a way to alter the activity of selected brain cells with precise timing. That capability is what opened new routes into the study of memory, emotion, behaviour and disease-related neural circuits.

Featured image. Source: Pexels. Credit: Edward Jenner. License: Pexels License.